{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:09:28Z","timestamp":1792634968920,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["TGM16MT1"],"award-info":[{"award-number":["TGM16MT1"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007195","name":"Universit\u00e0 degli Studi di Napoli Federico II","doi-asserted-by":"publisher","award":["F\/050298\/01\/X32"],"award-info":[{"award-number":["F\/050298\/01\/X32"]}],"id":[{"id":"10.13039\/100007195","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["694323"],"award-info":[{"award-number":["694323"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.omtm.2021.10.004","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T03:25:00Z","timestamp":1634873100000},"page":"448-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Inclusion of a degron reduces levels of undesired inteins after AAV-mediated protein trans-splicing in the retina"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0700-3007","authenticated-orcid":false,"given":"Patrizia","family":"Tornabene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3134-2973","authenticated-orcid":false,"given":"Ivana","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Centrulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Marrocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4136-4866","authenticated-orcid":false,"given":"Renato","family":"Minopoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Iodice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4955-7857","authenticated-orcid":false,"given":"Carlo","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Simonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2975-942X","authenticated-orcid":false,"given":"Enrico M.","family":"Surace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0832-2472","authenticated-orcid":false,"given":"Alberto","family":"Auricchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2021.10.004_bib1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ajmg.c.31842","article-title":"The new landscape of retinal gene therapy","volume":"84","author":"Ku","year":"2020","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet"},{"key":"10.1016\/j.omtm.2021.10.004_bib2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ophtha.2019.06.017","article-title":"Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials","volume":"126","author":"Maguire","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtm.2021.10.004_bib3","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","article-title":"Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial","volume":"383","author":"MacLaren","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2021.10.004_bib4","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jamaophthalmol.2019.3278","article-title":"Efficacy and safety of retinal gene therapy using adeno-associated virus vector for patients with choroideremia: a randomized clinical trial","volume":"137","author":"Fischer","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.omtm.2021.10.004_bib5","doi-asserted-by":"crossref","unstructured":"FDA approves hereditary blindness gene therapy (2018). Nat. Biotechnol. 36, 6.","DOI":"10.1038\/nbt0118-6a"},{"key":"10.1016\/j.omtm.2021.10.004_bib6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1128\/jvi.45.2.555-564.1983","article-title":"Nucleotide sequence and organization of the adeno-associated virus 2 genome","volume":"45","author":"Srivastava","year":"1983","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2021.10.004_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/hum.2019.220","article-title":"Can adeno-associated viral vectors deliver effectively large genes?","volume":"31","author":"Tornabene","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2021.10.004_bib8","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1093\/nar\/gkv601","article-title":"Development of an intein-mediated split-Cas9 system for gene therapy","volume":"43","author":"Truong","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2021.10.004_bib9","doi-asserted-by":"crossref","first-page":"eaav4523","DOI":"10.1126\/scitranslmed.aav4523","article-title":"Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina","volume":"11","author":"Tornabene","year":"2019","journal-title":"Sci. Transl Med."},{"key":"10.1016\/j.omtm.2021.10.004_bib10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1089\/hum.2008.009","article-title":"Protein trans-splicing as a means for viral vector-mediated in\u00a0vivo gene therapy","volume":"19","author":"Li","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2021.10.004_bib11","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.95.16.9226","article-title":"Protein trans-splicing by a split intein encoded in a split DnaE gene of Synechocystis sp. PCC6803","volume":"95","author":"Wu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.omtm.2021.10.004_bib12","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ncomms1927","article-title":"ABCA4 is an N-retinylidene-phosphatidylethanolamine and phosphatidylethanolamine importer","volume":"3","author":"Quazi","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2021.10.004_bib13","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/eji.200323490","article-title":"N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA","volume":"33","author":"Schnappauf","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtm.2021.10.004_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.chembiol.2013.03.005","article-title":"A LOV2 domain-based optogenetic tool to control protein degradation and cellular function","volume":"20","author":"Renicke","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.omtm.2021.10.004_bib15","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/emboj\/17.10.2759","article-title":"Degradation signals for ubiquitin system proteolysis in Saccharomyces cerevisiae","volume":"17","author":"Gilon","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.omtm.2021.10.004_bib16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gad.1884910","article-title":"A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity","volume":"24","author":"Cho","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtm.2021.10.004_bib17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.chembiol.2010.07.009","article-title":"A general chemical method to regulate protein stability in the mammalian central nervous system","volume":"17","author":"Iwamoto","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.omtm.2021.10.004_bib18","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1093\/hmg\/ddv386","article-title":"Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease","volume":"24","author":"Trapani","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2021.10.004_bib19","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.chembiol.2020.03.006","article-title":"Simultaneous control of endogenous and user-defined genetic pathways using unique ecDHFR pharmacological chaperones","volume":"27","author":"Ramadurgum","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.omtm.2021.10.004_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.omtm.2019.08.002","article-title":"Non-antibiotic small-molecule regulation of DHFR-based destabilizing domains in\u00a0vivo","volume":"15","author":"Peng","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2021.10.004_bib21","doi-asserted-by":"crossref","first-page":"e46269","DOI":"10.1371\/journal.pone.0046269","article-title":"Destabilizing domains mediate reversible transgene expression in the brain","volume":"7","author":"Tai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2021.10.004_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cvfa.2010.09.002","article-title":"Porcine ophthalmology","volume":"26","author":"Middleton","year":"2010","journal-title":"Vet. Clin. North Am. Food Anim. Pract."},{"key":"10.1016\/j.omtm.2021.10.004_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12974-017-0915-5","article-title":"MHC class II expression and potential antigen-presenting cells in the retina during experimental autoimmune uveitis","volume":"14","author":"Lipski","year":"2017","journal-title":"J.\u00a0Neuroinflamm."},{"key":"10.1016\/j.omtm.2021.10.004_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/09273949709085049","article-title":"MHC class II positive retinal pigment epithelial (RPE) cells can function as antigen-presenting cells for microbial superantigen","volume":"5","author":"Osusky","year":"1997","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.omtm.2021.10.004_bib25","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/j.ymthe.2018.07.016","article-title":"A drug-tunable gene therapy for broad-spectrum protection against retinal degeneration","volume":"26","author":"Santiago","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.10.004_bib26","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1167\/iovs.18-24987","article-title":"A destabilizing domain allows for fast, noninvasive, conditional control of protein abundance in the mouse eye - implications for ocular gene therapy","volume":"59","author":"Datta","year":"2018","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2021.10.004_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.omtm.2018.08.008","article-title":"Destabilizing domains enable long-term and inert regulation of GDNF expression in the brain","volume":"11","author":"Quintino","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2021.10.004_bib28","series-title":"The Human Eye: Structure and Function","author":"Oyster","year":"2007"},{"key":"10.1016\/j.omtm.2021.10.004_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0042-6989(85)90076-8","article-title":"A schematic eye for the mouse, and comparisons with the rat","volume":"25","author":"Remtulla","year":"1985","journal-title":"Vis. Res."},{"key":"10.1016\/j.omtm.2021.10.004_bib30","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1089\/104303400750001390","article-title":"Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in\u00a0vivo","volume":"11","author":"Gao","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2021.10.004_bib31","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.febslet.2009.02.003","article-title":"The naturally split Npu DnaE intein exhibits an extraordinarily high rate in the protein trans-splicing reaction","volume":"583","author":"Zettler","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtm.2021.10.004_bib32","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.febslet.2006.02.045","article-title":"Highly efficient protein trans-splicing by a naturally split DnaE intein from Nostoc punctiforme","volume":"580","author":"Iwai","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtm.2021.10.004_bib33","doi-asserted-by":"crossref","first-page":"14009","DOI":"10.1038\/mtm.2014.9","article-title":"Specific tools for targeting and expression in Muller glial cells","volume":"1","author":"Pellissier","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2021.10.004_bib34","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1167\/iovs.07-0257","article-title":"AAV-mediated expression targeting of rod and cone photoreceptors with a human rhodopsin kinase promoter","volume":"48","author":"Khani","year":"2007","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2021.10.004_bib35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/hgtb.2013.155","article-title":"AAV2\/8 vectors purified from culture medium with a simple and rapid protocol transduce murine liver, muscle, and retina efficiently","volume":"24","author":"Doria","year":"2013","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2021.10.004_bib36","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ymthe.2017.11.019","article-title":"Triple vectors expand AAV transfer capacity in the retina","volume":"26","author":"Maddalena","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.10.004_bib37","first-page":"125","article-title":"Intraocular delivery of recombinant virus","volume":"47","author":"Liang","year":"2001","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.omtm.2021.10.004_bib38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/gt.2011.3","article-title":"AAV-mediated photoreceptor transduction of the pig cone-enriched retina","volume":"18","author":"Mussolino","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2021.10.004_bib39","doi-asserted-by":"crossref","first-page":"11372","DOI":"10.1128\/JVI.01327-07","article-title":"Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors","volume":"81","author":"Allocca","year":"2007","journal-title":"J.\u00a0Virol."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:29:13Z","timestamp":1762421353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050121001613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"alternative-id":["S2329050121001613"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2021.10.004","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inclusion of a degron reduces levels of undesired inteins after AAV-mediated protein trans-splicing in the retina","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2021.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}